These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26169541)

  • 1. Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats.
    Kojima N; Williams JM; Slaughter TN; Kato S; Takahashi T; Miyata N; Roman RJ
    Physiol Rep; 2015 Jul; 3(7):. PubMed ID: 26169541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats.
    Kojima N; Williams JM; Takahashi T; Miyata N; Roman RJ
    J Pharmacol Exp Ther; 2013 Jun; 345(3):464-72. PubMed ID: 23492941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.
    Williams JM; Murphy SR; Wu W; Border JJ; Fan F; Roman RJ
    Geroscience; 2022 Dec; 44(6):2845-2861. PubMed ID: 35767209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
    Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.
    Williams JM; Zhang J; North P; Lacy S; Yakes M; Dahly-Vernon A; Roman RJ
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F983-98. PubMed ID: 21228113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure.
    Brown AK; Nichols A; Coley CA; Ekperikpe US; McPherson KC; Shields CA; Poudel B; Cornelius DC; Williams JM
    Front Physiol; 2021; 12():765305. PubMed ID: 34975523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G
    Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnosine treatment in combination with ACE inhibition in diabetic rats.
    Peters V; Riedl E; Braunagel M; Höger S; Hauske S; Pfister F; Zschocke J; Lanthaler B; Benck U; Hammes HP; Krämer BK; Schmitt CP; Yard BA; Köppel H
    Regul Pept; 2014 Nov; 194-195():36-40. PubMed ID: 25234296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
    Sakai M; Uchii M; Myojo K; Kitayama T; Kunori S
    Eur J Pharmacol; 2015 Aug; 761():109-15. PubMed ID: 25936515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.
    Gagliardini E; Corna D; Zoja C; Sangalli F; Carrara F; Rossi M; Conti S; Rottoli D; Longaretti L; Remuzzi A; Remuzzi G; Benigni A
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1448-56. PubMed ID: 19675181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.
    Sevak AR; Goyal RK
    Pharmacol Res; 1996; 34(5-6):201-9. PubMed ID: 9076844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse renal effects of the AGE inhibitor pyridoxamine in combination with ACEi in non-diabetic adriamycin-induced renal damage in rats.
    Waanders F; van Goor H; Navis G
    Kidney Blood Press Res; 2008; 31(5):350-9. PubMed ID: 19018148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
    Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
    Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
    Wienen W; Richard S; Champeroux P; Audeval-Gerard C
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):31-6. PubMed ID: 11881063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E ameliorates the renal injury of Dahl salt-sensitive rats.
    Atarashi K; Ishiyama A; Takagi M; Minami M; Kimura K; Goto A; Omata M
    Am J Hypertens; 1997 May; 10(5 Pt 2):116S-119S. PubMed ID: 9160794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of left ventricular function and coronary flow by angiotensin I-converting enzyme inhibition in the hypertensive-diabetic Dahl rat.
    Given MB; Lowe RF; Gelvin CR; Sander GE; Giles TD
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):919-25. PubMed ID: 7826556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid development of glomerulosclerosis in diabetic Dahl salt-sensitive rats.
    Körner A; Jaremko G; Eklöf AC; Aperia A
    Diabetologia; 1997 Apr; 40(4):367-73. PubMed ID: 9112012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.